KRAS is one of the oncogenes most frequently altered in cancer, mutated in approximately one-third of lung adenocarcinomas.

A new review article highlights the powerful influence of long non-coding RNAs (lncRNAs) in regulating natural killer (NK) cells, revealing promising opportunities to enhance immune responses and ...

Researchers added paricalcitol to chemotherapy and assessed outcomes in metastatic pancreatic cancer. The treatment remodeled ...

Across the immunity cycle, NPs can co-deliver tumor antigens and adjuvants to DCs, enhance major histocompatibility complex class I (MHC-I)-mediated cross-presentation, and promote cytotoxic T ...

Since scientists first discovered that human immune cells could be modified to become cancer-fighting agents, they’ve been trying to engineer a cell that’s effective against solid tumors, which ...

The field of cancer immunotherapy has witnessed remarkable progress over the past decade, offering durable benefits for subsets of patients across multiple ...

When activated in ovarian cancer cells, the receptor for the body's primary stress hormone alters the tumor environment in ...